site:mg-alc.co.kr 검색 결과
인기글
-
정신 놓고 씨부리봐~ 2023.11.22. - 건설현장 안전관리 차근차근 따라하기 2023.12.20.
-
쉘코퍼레이션 공식 팀 블로그 공식 2024.04.04. -
모두의 건프라! (Gunpla For Everyone) 대표 2023.07.28. - 리치캣의 현재 그리고 미래 2023.05.21.
-
덕필아재의 개인공방 2022.06.22. -
곰 마을 재테크 (월급쟁이,펀드,보험,주식,예적금,코인,부동산,) 2020.07.10.
학술정보
- AbstractFrom pure experimental isotherms and ideal adsorbed solution theory (IAST), we confirmed a recent report that Co-MOF-74 provides the highest Xe uptake as well as the highest Xe/Kr selectivity among the three M-MOF-74 series (M = Co, Mg, and Zn). From breakthrough experiments, we then showed the first demonstration of the potential of Co-MOF-74 for Xe/Kr separations under mixture flow conditions. Remarkably, the experimental breakthroug(2016) Seung-Joon Lee 외 4명31회 피인용Elsevier / Microporous And Mesoporous Materials학술논문
- Predictions of global climate change have recently focused attention on soils as major sources and sinks for atmospheric CO 2, and various methodologies exist for measuring soil surface CO 2 flux. A static (passive CO 2 absorption in an alkali trap over 24 h) and a dynamic (portable infra-red CO 2 gas analyzer over 1–2 min) chamber method were compared. Both methods were used for 100 different site × treatment × time combinations in temperat(1996) L.S. Jensen 외 5명116회 피인용Elsevier / Soil Biology & Biochemistry학술논문
- Abstract Background Remimazolam is a new anesthetic drug developed and an ultra-short-acting agent with rapid onset offset. The pharmacology of this seems to be ideal for short surgeries eligible I-gel insertion. Therefore, study aimed determine the optimal bolus dose remimazolam insertion when co-administered remifentanil without neuromuscular blocking agents (NMBAs). Methods Patients aged 19–65 years American Society Anesthesiologists physic 학술논문
- BackgroundRemimazolam is a new anesthetic drug developed and is an ultra-short-acting agent with rapid onset and offset. The pharmacology of this drug seems to be ideal for short surgeries eligible for I-gel insertion. Therefore, this study aimed to determine the optimal bolus dose of remimazolam for I-gel insertion when co-administered with remifentanil without neuromuscular blocking agents (NMBAs). MethodsPatients aged 19–65 years with Amer 학술논문
- BackgroundRemimazolam is a new anesthetic drug developed and is an ultra-short-acting agent with rapid onset and offset. The pharmacology of this drug seems to be ideal for short surgeries eligible for I-gel insertion. Therefore, this study aimed to determine the optimal bolus dose of remimazolam for I-gel insertion when co-administered with remifentanil without neuromuscular blocking agents (NMBAs). MethodsPatients aged 19–65 years with Amer 학술논문
RE예... 맞아요. 가을쯤에 예정되어있으니 미리 준비해야죠.
RE가입자가 알아야 눈탱이 맞지 않을정보네요ㅠㅠㅠ 감사합니다~ 상품 없어지기전에 부지런히 알아봐야겠어요!!!!!
RE양성뇌종양은 혈관이 아니군요 이왕이면 꼭넣는게 좋겠어요
RE그렇군요 소문으로는. 농협이 좋다해서요~감사합니다
RE엠지 어린이보험이 요즘 핫하죠.상세한 설명 감사합니다 ^^